Dekkers Marijn E
CIK 0001216068
Director
Filings
12
Latest Aug 5, 2024
Issuers covered
3
Showing
12 of 12
Page 1
Track record
2 of 3 open-market trades scored (67% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +47.7% | +47.7% | +48.9% | +46.5% |
| 90 days | 2 | 100% | +70.4% | +70.4% | +71.2% | +69.6% |
| 180 days | 2 | 100% | +74.8% | +74.8% | +75.0% | +74.6% |
| 365 days | 2 | 100% | +76.8% | +76.8% | +77.3% | +76.4% |
Issuers
Companies where Dekkers Marijn E has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DNA | Ginkgo Bioworks Holdings, Inc. | 6 | Jun 14, 2024 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 5 | Aug 5, 2024 |
| QSI | Quantum-Si Inc | 1 | May 13, 2022 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|